- Home
- AGEN vs ISPO Comparison
AGEN vs ISPO Comparison
Compare AGEN & ISPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- ISPO
- Stock Information
- Founded
- AGEN 1994
- ISPO 2010
- Country
- AGEN United States
- ISPO United States
- Employees
- AGEN N/A
- ISPO N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- ISPO Blank Checks
- Sector
- AGEN Health Care
- ISPO Finance
- Exchange
- AGEN Nasdaq
- ISPO Nasdaq
- Market Cap
- AGEN 52.6M
- ISPO 43.1M
- IPO Year
- AGEN 2000
- ISPO N/A
- Fundamental
- Price
- AGEN $2.91
- ISPO $3.55
- Analyst Decision
- AGEN Buy
- ISPO
- Analyst Count
- AGEN 4
- ISPO 0
- Target Price
- AGEN $8.00
- ISPO N/A
- AVG Volume (30 Days)
- AGEN 830.5K
- ISPO 27.9K
- Earning Date
- AGEN 05-12-2025
- ISPO 05-07-2025
- Dividend Yield
- AGEN N/A
- ISPO N/A
- EPS Growth
- AGEN N/A
- ISPO N/A
- EPS
- AGEN N/A
- ISPO N/A
- Revenue
- AGEN $103,463,000.00
- ISPO $265,499,000.00
- Revenue This Year
- AGEN $4.03
- ISPO N/A
- Revenue Next Year
- AGEN $5.57
- ISPO $148.70
- P/E Ratio
- AGEN N/A
- ISPO N/A
- Revenue Growth
- AGEN N/A
- ISPO N/A
- 52 Week Low
- AGEN $1.38
- ISPO $3.11
- 52 Week High
- AGEN $19.69
- ISPO $9.31
- Technical
- Relative Strength Index (RSI)
- AGEN 59.81
- ISPO 47.63
- Support Level
- AGEN $2.87
- ISPO $3.15
- Resistance Level
- AGEN $3.16
- ISPO $3.65
- Average True Range (ATR)
- AGEN 0.35
- ISPO 0.28
- MACD
- AGEN 0.02
- ISPO 0.02
- Stochastic Oscillator
- AGEN 56.25
- ISPO 56.96
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About ISPO Inspirato Incorporated
Inspirato Inc is a private, luxury hospitality club that provides its members with access to an exclusive portfolio of high-end vacation homes, luxury hotels, and curated travel experiences worldwide. The club offers personalized service, dedicated trip planning, and seamless access to exceptional properties through its innovative model designed to ensure the service, certainty and value that discerning customers demand. The Inspirato portfolio of curated luxury vacation options includes approximately 350 private luxury vacation homes and accommodations at over 220 luxury hotel and resort partners in over 180 destinations around the world.